SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Dragonfly Energy filed an exhibit detailing its matters for the upcoming annual meeting, including proposals for ratification of accountants and elect...
The company announced the acquisition of Paulson’s 40% stake in its Alaska project and increased treasury to $343.4M. This all-share agreement s...
DiamondRock Hospitality Company announced the acquisition of a luxury resort in Delaware for $31.0 million, funded by cash on hand. The deal is projec...
Hyperfine Inc. announced a record third-quarter revenue of approximately $6.0 million and reaffirmed full-year 2026 guidance, reflecting strong execut...
ConnectOne Bancorp announced that it plans to release third quarter 2026 results on October 22, 2026, and host a conference call with management....
AngioDynamics reported an 6.9% increase in Net Sales to $80.9 million for Q1 FY27, driven by double-digit Med Tech growth. The company also announced ...
AngioDynamics Inc announced a definitive employment agreement with Eric Honroth to serve as CEO and President starting November 2, 2026. This leadersh...
Ernst & Young LLP filed a consent allowing its independent report to be included in various ongoing SEC registration statements, filed October 8, 2026...
Shoulder Innovations initiated a limited user release of its InSet Go glenoid implant following the completion of its first clinical case, representin...
Editas Medicine received approval to initiate the Phase 1/2 Strive trial of EDIT-401 in Australia to treat hyperlipidemia, with plans to report initia...
Tetra Technologies Inc. agreed to amend its credit agreement with Silver Point Finance as the administrative agent, effective October 2, 2026....
Tilray reported record revenue and gross profit but reaffirmed adjusted EBITDA guidance, reflecting a shift toward profitability across beverage and i...
Henry Schein is offering the position of Senior Vice President and CFO to Emmanuel Caprais. The appointment is pending commencement and includes signi...
Atrium Therapeutics issued pre-funded warrants to purchase common stock, granting holders purchase rights at $0.001 per share starting in 2026. The wa...
The company beat adjusted EPS for Q2 FY27 despite higher costs and issued updated sales and EPS guidance for the full year....
Nova Minerals' antimony processing equipment has arrived at Port MacKenzie, enabling construction to begin, marking a key milestone for the company's ...
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Prota Financial, LLC....
Perspective Therapeutics announced FDA Fast Track Designation for PSV359 treating rare fibroblast activation protein-positive solitary fibrous tumors....
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Neumann Advisory Hong Kong Ltd....
Drilling Tools International Corp signed a definitive agreement to sell its interests to Casings Technologies Group and others. The deal, valued at $9...